Low-dose rituximab protocol in rheumatoid arthritis—outcome and economic impact

OBJECTIVES: A significant proportion of RA patients, particularly those associated with poor prognostic factors, fail on conventional DMARDs (cDMARDs). Although rituximab (RTX) has been effective in these patients, the cost of therapy makes it unaffordable, particularly in poor and developing countr...

Descripción completa

Detalles Bibliográficos
Autores principales: Chandramohan, Parvathypriya, Jain, Avinash, Antony, Glindow, Krishnan, Narayanan, Shenoy, Padmanabha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878847/
https://www.ncbi.nlm.nih.gov/pubmed/33605940
http://dx.doi.org/10.1093/rap/rkaa077

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878847/
https://www.ncbi.nlm.nih.gov/pubmed/33605940
http://dx.doi.org/10.1093/rap/rkaa077

Ejemplares similares